Is It Lawful, Ethical to Prioritize Racial Minorities for COVID-19 Vaccines?

JAMA

EMBARGOED FOR RELEASE: 11 A.M. (ET), WEDNESDAY, OCTOBER 14, 2020

Media advisory: The full article is linked to this news release. A live stream at 12:15 P.M. (ET) on Wednesday accompanies this article and can be accessed at this link https://ja.ma/GostinWilliams

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2020.20571?guestAccessKey=7991dc73-1b46-4993-b3a9-84c64689f4cb&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=101420

 

What The Viewpoint Says: How COVID-19 vaccines can be distributed strategically, ethically and legally is considered in this article given conflicts between consensus public health recommendations to prioritize allocation to disadvantaged racial and ethnic minorities and laws discouraging explicit consideration of race in policy decisions.

Authors: Lawrence O. Gostin, J.D., of Georgetown University in Washington, is the corresponding author.

 

(doi:10.1001/jama.2020.20571)

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

#  #  #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.